Balyasny Asset Management
ALLO icon

Balyasny Asset Management’s Allogene Therapeutics ALLO Stock Holding History

Balyasny Asset Management’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Buy
+1,182,816
New +$2.37M ﹤0.01% 1615
2024
Q3 		– Sell
-53,622
Closed -$125K – 2707
2024
Q2 		$125K Buy
53,622
+32,305
+152% +$95.3K ﹤0.01% 2390
2024
Q1 		$95.3K Buy
21,317
+5,587
+36% +$23.3K ﹤0.01% 2497
2023
Q4 		$50.5K Buy
+15,730
New +$44.6K ﹤0.01% 2407
2023
Q1 		– Sell
-168,388
Closed -$1.06M – 2601
2022
Q4 		$1.06M Buy
168,388
+126,909
+306% +$1.17M ﹤0.01% 1633
2022
Q3 		$448K Buy
+41,479
New +$564K ﹤0.01% 2067
2021
Q2 		– Sell
-98,208
Closed -$3.47M – 1932
2021
Q1 		$3.47M Buy
+98,208
New +$3.31M 0.02% 837
2020
Q4 		– Sell
-147,059
Closed -$5.55M – 1285
2020
Q3 		$5.55M Buy
+147,059
New +$5.54M 0.04% 575

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return